Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis
NCT03822325 is an observational study sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. As of 21 Nov 2026, it is active and no longer recruiting. It studies Eosinophilic Esophagitis. The registry lists an enrollment of 88 participants at 2 sites in 1 country. The registry lists a start date of 28 Feb 2011 and a primary completion date of 31 May 2015.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT03822325 |
| Status | Active not recruiting |
| Study type | Observational study |
| Lead sponsor | Ann & Robert H Lurie Children's Hospital of Chicago |
| Enrollment | 88 |
| Registered sites | 2 |
| Countries | 1 |
| Conditions | Eosinophilic Esophagitis |
| Start | 28 Feb 2011 |
| Primary completion | 31 May 2015 |
| Study completion | 30 Nov 2027 |
| Last update posted | 5 Jun 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Barry Wershil, MD
Ann & Robert H. Lurie Children's Hospital fo Chicago
Principal Investigator - Joshua Wechsler, MD
Ann & Robert H Lurie Children's Hospital of Chicago
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ann & Robert H Lurie Children's Hospital of Chicago
Chicago
- University of Illinois at Chicago (uic)
Chicago
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT03822325
Each answer restates registry values shown on this page.
What is NCT03822325?
NCT03822325 is an observational study sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. It studies Eosinophilic Esophagitis.
Is NCT03822325 recruiting?
As of 21 Nov 2026, it is active and no longer recruiting.
Who leads NCT03822325?
The registry names Barry Wershil, MD (principal investigator, Ann & Robert H. Lurie Children's Hospital fo Chicago) and Joshua Wechsler, MD (principal investigator, Ann & Robert H Lurie Children's Hospital of Chicago) as overall officials.
Where does NCT03822325 run?
The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.
When is NCT03822325 expected to complete?
The registry lists a primary completion date of 31 May 2015 and a study completion date of 30 Nov 2027. The sponsor last updated the record on 5 Jun 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.